Current prescribing patterns in outpatient child and adolescent psychiatric practice in central New York

Journal of Child and Adolescent Psychopharmacology

Volumn 15, Issue 1, 2005, Pages 57-61

  Staller, Jud A ^a   Wade, Michael J ^a   Baker, Molly ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CENTRAL STIMULANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; AGE; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHILD; CHILD PSYCHIATRY; CLINICAL PRACTICE; DEPRESSION; DRUG DOSE REGIMEN; ENDOCRINE DISEASE; FEMALE; GENDER; HUMAN; HYPERLIPIDEMIA; HYPERPROLACTINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; OUTPATIENT CARE; POLYPHARMACY; PRESCRIPTION; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; RACE; SIDE EFFECT; SUICIDAL BEHAVIOR; UNITED STATES;

ADOLESCENT; ADOLESCENT PSYCHIATRY; AMBULATORY CARE; CHILD; CHILD PSYCHIATRY; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEW YORK; PRESCRIPTIONS, DRUG; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES;

EID: 14944352183     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2005.15.57     Document Type: Article

References (11)

1. Connor DF, Ozbayrak KR, Harrison RJ, Melloni RH Jr.: Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment. J Child Adolesc Psychopharmacol 8(1):27-38, 1998.
2. Kaplan S, Simms R, Busner J: Prescribing practices of outpatient child psychiatrists. J Am Acad Child Adolesc Psychiatry 33(1):35-44, 1994.
3. Leonard, H: British government broadens warning against SSRI use in depressed youth. [editorial] The Brown University Child and Adolescent Psychopharmacology Update. 6(1):3, 2004.
4. Martin A, Leslie D: Trends in psychotropic medication costs for children and adolescents, 1997-2000. Arch Pediatr Adolesc Med 157(10):997-1004, 2003.
5. Melkersson K, Dahl ML. Adverse metabolic effects associated with atypical antipsychotics: Literature review and clinical implications. Drugs 2004; 64(7):701-723.
6. Patel NC, Sanchez RJ, Johnsrud MT, Crimson ML: Trends in antipsychotic use in a Texas Medicaid population of children and adolescents: 1996-2000. J Child Adolesc Pyschopharmacol 12(3):221-229, 2002.
7. Reed E, Vance A, Luk E, Nunn K: Single and combined psychotropic medication use in a child and adolescent mental health service. Aust N Z J Psychiatry 38(4):204-211, 2004.
8. Riddle MA, Kastelic EA, Frosch E: Pediatric psychopharmacology. J Child Psychol Psychiatr 42(1):73-90, 2001.
9. Safer DJ: Changing patterns of psychotropic medications prescribed by child psychiatrists in the 1990s. J Child Adolesc Psychopharmacol 7(4): 267-274, 1997.
10. Safer DJ, Zito JM, dosReis S: Concomitant psychotropic medication for youths. Am J Psychiatry 160(3):438-449, 2003.
11. Zito JM, Safer DJ, dosReis S, Gardner J, Boles M, Lynch F: Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283(8): 1025-1030, 2000.